During the Trading Day
40.23 -0.76 / -1.85%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
40.23 0.00 / 0.00%
Volume: 5.8K
Health Technology

Company Description

TESARO, Inc. is an oncology-focused biopharmaceutical company. It is dedicated to improving the lives of cancer patients. The company's product portfolio currently consists of three oncology-related product candidates: Rolapitant, Niraparib and TSR-011. TESARO was founded by Leon Moulder, Jr., Mary Lynne Hedley and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA.

Contact Information

1000 Winter Street
Waltham Massachusetts 02451
P:(339) 970-0900
Investor Relations:
(781) 325-1116



Individual stakeholders43.46%
Mutual fund holders40.36%
Other institutional26.48%

Top Executives

Leon O. MoulderChief Executive Officer & Director
Mary Lynne HedleyPresident, Chief Operating Officer & Director
Timothy R. PearsonChief Financial Officer & Executive Vice President
Robert E. MartellChief Medical Officer
Lori Rudolph-OwenVP-Portfolio Management, Research & Development

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.